# LANXESS will acquire IFF's microbial control business/Progress of Xinhecheng Methionine Project

> LANXESS agreed on August 23, 2021 to acquire IFF's microbial control business for about US$450 million in sales, with closing expected in Q2 2022. The article also references progress on Xinhecheng's methionine project.

- Date: 2021-08-30 · published 2021-08-30T12:00:00.000Z
- Category: market · region Global · magnitude low
- Page: https://feedsoft.ai/events/45892-lanxess-will-acquire-iff-s-microbial-control-business-progress-of-xinhecheng
- Commodities: [Methionine](https://feedsoft.ai/c/METH.md)

## Why it matters

The deal is a specialty chemicals acquisition with little direct effect on feed commodity supply or prices, though the methionine project mention has limited relevance to feed amino acid markets.

## Sources

- echemi.com: https://www.echemi.com/cms/329385.html

---
Data from Feedsoft AI (https://feedsoft.ai/). For information only; not investment advice.